Follow
Feixiong Cheng
Title
Cited by
Cited by
Year
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
42862018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
24942018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
23772018
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
21052018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
19762018
admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties
F Cheng, W Li, Y Zhou, J Shen, Z Wu, G Liu, PW Lee, Y Tang
Journal of chemical information and modeling 52 (11), 3099-3105, 2012
18502012
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Y Zhou, Y Hou, J Shen, Y Huang, W Martin, F Cheng
Cell discovery 6 (1), 14, 2020
15552020
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
15272018
Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas
TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ...
Cell reports 23 (1), 239-254. e6, 2018
8932018
Prediction of drug-target interactions and drug repositioning via network-based inference
F Cheng, C Liu, J Jiang, W Lu, W Li, G Liu, W Zhou, J Huang, Y Tang
PLoS computational biology 8 (5), e1002503, 2012
8712012
Genomic and functional approaches to understanding cancer aneuploidy
AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ...
Cancer cell 33 (4), 676-689. e3, 2018
8242018
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma
CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ...
Cell reports 23 (1), 313-326. e5, 2018
8102018
Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images
J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ...
Cell reports 23 (1), 181-193. e7, 2018
8012018
Comprehensive analysis of alternative splicing across tumors from 8,705 patients
A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ...
Cancer cell 34 (2), 211-224. e6, 2018
6952018
Pathogenic germline variants in 10,389 adult cancers
K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ...
Cell 173 (2), 355-370. e14, 2018
6932018
Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines
K Ellrott, MH Bailey, G Saksena, KR Covington, C Kandoth, C Stewart, ...
Cell systems 6 (3), 271-281. e7, 2018
6302018
Network-based prediction of drug combinations
F Cheng, IA Kovács, AL Barabási
Nature communications 10 (1), 1197, 2019
6192019
A comprehensive pan-cancer molecular study of gynecologic and breast cancers
AC Berger, A Korkut, RS Kanchi, AM Hegde, W Lenoir, W Liu, Y Liu, ...
Cancer cell 33 (4), 690-705. e9, 2018
5382018
Driver fusions and their implications in the development and treatment of human cancers
Q Gao, WW Liang, SM Foltz, G Mutharasu, RG Jayasinghe, S Cao, ...
Cell reports 23 (1), 227-238. e3, 2018
4702018
Comparative molecular analysis of gastrointestinal adenocarcinomas
Y Liu, NS Sethi, T Hinoue, BG Schneider, AD Cherniack, F Sanchez-Vega, ...
Cancer cell 33 (4), 721-735. e8, 2018
4692018
The system can't perform the operation now. Try again later.
Articles 1–20